国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Gilead Sciences unveils campaign to help women fight cancer

By Zhong Nan | chinadaily.com.cn | Updated: 2024-03-15 16:05
Share
Share - WeChat
The booth of Gilead Sciences at the fifth China International Import Expo in Shanghai on Nov 7, 2022. [Photo/VCG]

Gilead Sciences, a research-based biopharmaceutical company from California, launched a women's health advocacy campaign in China on Wednesday built around the idea of "taking back" the possibilities that cancer causes.

Themed "Cancer steals possibility. We're taking it back", the campaign, partnered with Marie Claire, a renowned women's lifestyle and fashion media, is a part of Gilead's global oncology franchise campaign. The project unites triple-negative breast cancer patients, authoritative medical experts and influential female representatives to share their personal experiences and stories of mutual support in the fight against cancer.

Breast cancer has become the leading type of cancer worldwide, with "triple-negative breast cancer" being a particularly difficult subtype to treat. This type of disease accounts for about between 10 to 15 percent of all breast cancers, according to information released by Atlanta-based American Cancer Society.

This form of breast cancer is highly aggressive and more likely to recur and spread than other types, posing a significant challenge for patient prognosis. The five-year survival rate for individuals with advanced metastatic triple-negative breast cancer is a mere 12.2 percent.

Jin Fangqian, vice-president of Gilead Sciences and the group's general manager for China, said as an innovation-driven company, Gilead is not only committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer, but also striving to remedy health inequities and break down barriers to care.

"By launching this campaign, we hope to further raise awareness of women's health in local society, enhance public understanding of breast cancer prevention and treatment, and help patients regain the possibilities in their lives," said Jin, adding the company will continue to invest in innovative research and development in the field of breast cancer and broader cancer types.

Gilead commenced its commercial operations in China in 2017, initially on virology focusing on HIV prevention and treatment, and viral hepatitis. By 2023, the company expanded into the oncology sector, introducing a new treatment option to China for patients with inoperable locally advanced or metastatic triple-negative breast cancer, offering innovative treatment option for those affected by this challenging condition.

In response to the Health China 2030 Initiative, the company has also collaborated with governments, associations, hospitals and research institutions to bring its innovative treatments to larger patient populations.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
民乐县| 富裕县| 肃宁县| 深州市| 肃宁县| 北川| 个旧市| 江门市| 丹阳市| 临西县| 弥渡县| 龙南县| 道真| 耒阳市| 长春市| 云南省| 利辛县| 岐山县| 兴化市| 宜宾县| 集安市| 东莞市| 津南区| 汝南县| 中西区| 龙川县| 和政县| 通河县| 始兴县| 屏东县| 金坛市| 浦北县| 玛曲县| 大石桥市| 东安县| 彰化市| 方正县| 登封市| 清镇市| 鄯善县| 依兰县|